We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
RNS Number:7480W Cambridge Antibody Tech Group PLC 31 May 2002 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company Cambridge Antibody Technology 2) Name of director Peter Chambre 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) As in 2 above 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Grant of options under Company Share Option Plan 7) Number of shares/amount of stock acquired 8) Percentage of issued class 9) Number of shares/amount of stock disposed 10) Percentage of issued class 11) Class of security 12) Price per share 13) Date of transaction 14) Date company informed 15) Total holding following this notification 16) Total percentage holding of issued class following this notification If a director has been granted options by the company please complete the following boxes 17) Date of grant 24 May 2002 18) Period during which or date on which exercisable 24 May 2005 - 23 May 2012 subject to performance conditions 19) Total amount paid (if any) for grant of the option Nil 20) Description of shares or debentures involved: class, number Ordinary 10p shares - 60,018 shares 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise £10.83 22) Total number of shares or debentures over which options held following this notification 60,018 23) Any additional information All of the 60,018 options granted will only become exercisable subject to the satisfaction of a performance condition and of that number 15,005 options will only become exercisable subject to the satisfaction of an additional more stringent performance condition. 24) Name of contact and telephone number for queries Justin Hoskins 01763 263233 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Company Secretary Date of Notification 31 May 2002 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company Cambridge Antibody Technology 2) Name of director John Aston 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest As in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) As in 2 above 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary Exercise of options under unapproved Executive Scheme 7) Number of shares/amount of stock acquired 10,000 8) Percentage of issued class 0.028% 9) Number of shares/amount of stock disposed Nil 10) Percentage of issued class Nil 11) Class of security Ordinary 10p shares 12) Price per share £3.00 13) Date of transaction 31 May 2002 14) Date company informed 31 May 2002 15) Total holding following this notification 21,857 16) Total percentage holding of issued class following this notification 0.060% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information 24) Name of contact and telephone number for queries Justin Hoskins 01763 263233 25) Name and signature of authorised company official responsible for making this notification Diane Mellett Company Secretary Date of Notification 31 May 2002 This information is provided by RNS The company news service from the London Stock Exchange
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions